Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives

Non-small-cell lung cancer (NSCLC) is one of the most common malignancies and the leading causes of cancer-related death worldwide. Despite many therapeutic advances in the past decade, NSCLC remains an incurable disease for the majority of patients. Molecular targeted therapies and immunotherapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Haiyang, Zhang, Jun, Qin, Chao, Yan, Hang, Liu, Tao, Hu, Haiyang, Tang, Shengjie, Tang, Shoujun, Zhou, Haining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600447/
https://www.ncbi.nlm.nih.gov/pubmed/36291069
http://dx.doi.org/10.3390/cells11203200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600447/
https://www.ncbi.nlm.nih.gov/pubmed/36291069
http://dx.doi.org/10.3390/cells11203200

Ejemplares similares